MINIMAL CHANGE DISEASE (MCD)
Clinical trials for MINIMAL CHANGE DISEASE (MCD) explained in plain language.
Never miss a new study
Get alerted when new MINIMAL CHANGE DISEASE (MCD) trials appear
Sign up with your email to follow new studies for MINIMAL CHANGE DISEASE (MCD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to keep rare kidney diseases in check
Disease control Recruiting nowThis study tests an injection called BAT4406F in people with two rare kidney diseases (MCD and FSGS) that cause protein leakage and swelling. The goal is to see if it can reduce protein in urine and prevent relapses better than a placebo. About 192 adults who have responded to st…
Matched conditions: MINIMAL CHANGE DISEASE (MCD)
Phase: PHASE2, PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
New pill could tame protein leak in kidney disease
Disease control Recruiting nowThis study tests an experimental drug called EVER001 in 45 adults with three types of kidney disease (FSGS, MCD, or IgAN) that cause protein to leak into urine. Participants take two capsules twice daily for 52 weeks. The goal is to see if the drug safely reduces protein levels a…
Matched conditions: MINIMAL CHANGE DISEASE (MCD)
Phase: PHASE2 • Sponsor: Everest Medicines (China) Co.,Ltd. • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC
-
Kidney disease mystery: scientists launch massive data hunt
Knowledge-focused Recruiting nowThis study is for people with rare kidney diseases like Minimal Change Disease, Focal Segmental Glomerulosclerosis, and Membranous Nephropathy. Researchers will collect health information and biological samples from 1,200 participants over many years. The goal is to better unders…
Matched conditions: MINIMAL CHANGE DISEASE (MCD)
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:05 UTC